Lee S Nguyen et al.(2022) nSMOL
Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept
J Immunother Cancer 2022;10:e004699
Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept
J Immunother Cancer 2022;10:e004699
PAGE TOP